T3	Subject 23 32	a patient
T4	Effect 37 79	developed a DAT-positive hemolytic episode
T5	Treatment 86 181	a red cell (RBC) transfusion was delivered during the infusion of her 17th cycle of oxaliplatin
T7	Drug 170 181	oxaliplatin
T9	Route 140 148	infusion
T10	Route 103 114	transfusion
T11	Drug 86 96	a red cell
T12	Duration 156 166	17th cycle
